Nobre, L., Zapotocky, M., Ramaswamy, V., Ryall, S., Bennett, J., Balaguer Guill, J., Baroni, L., Bartels, U., Bornhorst, M., Boue`, D., Chintagumpala, M., Cruz, O., Dahiya, S., Dirks, P., Dunkel, I., Eisenstat, D., Finch, E., Finlay, J., Frappaz, D., Luisa Garre, M., Gauvain, K., Grete Bechensteen, A., Hansford, J., Hauser, P., Huang, A., Karajannis, M., Kaur, G., Larouche, V., Lassaletta, A., Leary, S., Lin, F., McKeown, T., Milde, T., Morales La Madrid, A., Morse, H., Mushtaq, N., Osorio, D., Packer, R., Pavelka, Z., Salgado, D., Sabel, M., Solano, P., Su, J., Sumerauer, D., Toledano, H., van Tilburg, C., Wilson, B., Bouffet, E., Hawkins, C., & Tabori, U. (n.d.). pDCT-08. SUPERIOR OUTCOME FOR BRAF V600E PEDIATRIC GLIOMAS TREATED WITH TARGETED BRAF INHIBITION. Neuro-oncology, 21, vi184–vi185. http://access.bl.uk/ark:/81055/vdc_100094880242.0x00004d